IL-1β has been reported to accelerate hyperphosphorylation of tau in cultured cortical neurons, indicating that it may play a pivotal role in the progression of AD-related pathology [19], and IL-1β also has been shown to enhance ACT expression in mice [20]. This evidence concerns the gene IL1B and Alzheimer disease.